This series on “Clinic and Therapeutic Potential of Non-coding RNAs in Cancer” is edited by
- Joan Josep Castellano, PhD, Human Anatomy Unit, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain;
- Marina Díaz-Beyá, MD, PhD, Hematology department, Hospital Clinic of Barcelona, Barcelona, Spain; and
- Alfons Navarro, PhD, Human Anatomy and Embryology Unit, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
The present special series will explore todays knowledge about the potential role of ncRNAs in the clinic, especially in the liquid biopsy field, and intends to shed light into the future questions to be raised on this matter.
Clinic and therapeutic potential of non-coding RNAs in cancer
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies
Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role
Exosomal microRNAs in non-small cell lung cancer
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
Disclosure:
The special series “Clinic and Therapeutic Potential of Non-coding RNAs in Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Joan Josep Castellano, Marina Díaz-Beyá and Alfons Navarro served as the unpaid Guest Editors for the series.